Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 231,920	$ 105,504
Short-term receivables - settlement and other	2,005	452,376
Prepaid expenses	207,773	400,416
Total Current Assets	441,698	958,296
Equipment and furnishings, less accumulated depreciation of $47,015 and $36,445, respectively	75,999	86,569
Patents, net of accumulated amortization of $10,648,438 and $10,145,098, respectively	1,067,007	1,570,347
Long-term receivable – reimbursable legal fees, net of reserve for uncollectibility of $455,500	455,500	455,500
Long-term receivable – settlement, net of discount and reserve for uncollectibility of $1,549,043	382,016	365,685
Total Assets	2,422,220	3,436,397
Current Liabilities:
Accounts payable - trade	2,460,469	3,270,505
Other accrued expenses	789,552	327,143
Total Current Liabilities	3,250,021	3,597,648
Accrued interest	518,495	172,925
Accrued interest - related parties	580,311	228,667
Convertible notes payable	7,012,000	4,456,000
Convertible notes payable - related parties	6,350,000	5,000,000
Total Liabilities	17,710,827	13,455,240
Commitments and contingencies
Stockholders' Deficiency:
Preferred stock; par value $0.001 per share; 25,000,000 shares authorized; Series B Convertible Preferred Stock; 240,000 shares designated; 100 shares issued and outstanding at September 30, 2018 and December 31, 2017; aggregate liquidation preference of $3,500 at September 30, 2018 and December 31, 2017
Common stock; par value $0.001 per share; 1,000,000,000 shares authorized; 383,501,028 and 370,961,451 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively	383,502	370,962
Additional paid-in capital	209,033,950	208,351,431
Accumulated deficit	(224,706,059)	(218,741,236)
Total Stockholder's Deficiency	(15,288,607)	(10,018,843)
Total Liabilities and Stockholders' Deficiency	$ 2,422,220	$ 3,436,397